Aundrietta Duncan

Company: Salarius Pharmaceuticals

Job title: Director, Non-Clinical Development

Seminars:

Panel Discussion: Selecting The Best Model Depending on the Cancer Type: How To Do This? 8:30 am

• Pros and cons of the most commonly implemented models • Strategies to select the most appropriate model for your cancer study • Context of use for drug combination studies Moderated by: Daniela Dinulescu, Director, Tumor Immunobiology, ICC Discovery Group, Oncology R&D, Astra ZenecaRead more

day: Day One